Joint (JYNT) Stock Price, News & Analysis

Company Overview

The Joint Chiropractic, Inc., doing business as Joint (NASDAQ: JYNT), is a franchisor and operator of outpatient chiropractic clinics in the United States. Under its flagship The Joint Chiropractic brand, the company offers membership-based, cash-focused spinal adjustment services designed to promote accessible, routine care for neck and back discomfort. By removing insurance requirements and offering walk-in visits, Joint aims to streamline the patient experience and reduce cost barriers to ongoing chiropractic treatment.

Joint’s growth strategy centers on partnering with franchisees to expand its network of clinics. Since its founding in 1999, the company has opened over 700 locations across more than 25 states, serving a diverse customer base of both first-time and long-term patients. Joint employs standardized training programs, proprietary care protocols and technology-driven scheduling systems to ensure consistent service quality and operational efficiency across its franchise system.

Headquartered in Scottsdale, Arizona, Joint completed its initial public offering in late 2021, transitioning from a privately held franchisor to a publicly traded company. The business was founded by chiropractor Peter D. Holt, who continues to serve as Chief Executive Officer, overseeing national expansion efforts. With a focus on digital marketing, patient retention and incremental clinic growth, Joint seeks to capture a larger share of the growing U.S. chiropractic services market.

Key Stats

• Today's Range: $8.71 to $9.08
• 50-Day Range: $8.17 to $9.22
• 52-Week Range: $7.50 to $13.47
• Volume: 41,799 shs
• Average Volume: 72,355 shs
• Market Capitalization: $127.63 million
• P/E Ratio: 38.91
• Dividend Yield: N/A
• Price Target: $18.00
• Consensus Rating: Hold

Joint Stock Analysis - MarketRank™

Joint scored higher than 76% of companies evaluated by MarketBeat, and ranked 236th out of 867 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.6 / 5
• Analyst Rating: Hold

Consensus Rating

Joint has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 strong buy rating, no buy ratings, 1 hold rating, and 1 sell rating.

Upside Potential

Joint has a consensus price target of $18.00, representing about 101.1% upside from its current price of $8.95.

Amount of Analyst Coverage

Joint has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 23.53%

Earnings Growth

Earnings for Joint are expected to grow by 23.53% in the coming year, from $0.51 to $0.63 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Joint is 38.91, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.78.

Price to Earnings Ratio vs. Sector

The P/E ratio of Joint is 38.91, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 21.22.

Price to Book Value per Share Ratio

Joint has a P/B Ratio of 8.21. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

8.19% of the float of Joint has been sold short.

Short Interest Ratio / Days to Cover

Joint has a short interest ratio ("days to cover") of 22.72, which indicates bearish sentiment.

Change versus previous month

Short interest in Joint has recently decreased by 11.91%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Joint does not currently pay a dividend.

Dividend Growth

Joint does not have a long track record of dividend growth.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: 0.00

News Coverage This Week

MarketBeat has tracked 2 news articles for Joint this week, compared to 3 articles on an average week.

Company Ownership

• Score: 4.3 / 5
• Insider Trading: Acquiring Shares

Net Insider Buying

Over the last three months, insiders have purchased a net $1,098,551.00 in company stock, which represents 0.8608% of the company's market cap.

Insider Buying vs. Insider Selling

In the past three months, Joint insiders have bought more of their company's stock than they have sold. Specifically, they have bought $1,098,551.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

30.20% of the stock of Joint is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

76.88% of the stock of Joint is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 5/07/2026
• Today: 5/26/2026
• Next Earnings (Estimated): 8/06/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - HMO
• Sub-Industry: Trading
• Current Symbol: NASDAQ:JYNT
• CIK: 1612630
• Web: www.thejoint.com
• Phone: (480) 245-5960
• Fax: 480-513-7989
• Employees: 320
• Year Founded: 1999

Price Target and Rating

• Average Price Target for Joint: $18.00
• High Price Target: $18.00
• Low Price Target: $18.00
• Potential Upside/Downside: +101.1%
• Consensus Rating: Hold
• Rating Score (0-4): 2.33
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.23
• Trailing P/E Ratio: 38.91
• Forward P/E Ratio: 17.55
• P/E Growth: N/A
• Net Income: $2.91 million
• Net Margins: 5.72%
• Pretax Margin: 2.43%
• Return on Equity: 7.00%
• Return on Assets: 2.05%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.64
• Quick Ratio: 1.64

Sales & Book Value

• Annual Sales: $54.90 million
• Price / Sales: 2.32
• Cash Flow: $0.10 per share
• Price / Cash Flow: 92.01
• Book Value: $1.09 per share
• Price / Book: 8.21

Miscellaneous

• Outstanding Shares: 14,260,000
• Free Float: 9,950,000
• Market Cap: $127.63 million
• Optionable: Optionable
• Beta: 1.11